Julio 14, 2014
Nemak continues to post strong results; Sigma completes tender offer for Campofrio

Monterrey, N.L., Mexico. July 14, 2014.- ALFA, S.A.B de C.V. ("ALFA") announced today unaudited financial results for the quarter ended June 30, 2014 ("2Q14"). Revenues were slightly lower year-on-year, while EBITDA1 increased 1%, reaching U.S. $4,024 million and U.S. $510 million, respectively.

Explaining 2Q14 results, Mr. Alvaro Fernandez, ALFA's President, said "Nemak reported record EBITDA results, benefitting from robust sales in North America and a recovery in Europe. Sigma, Alestra and Newpek performed satisfactorily. In turn, Alpek posted a mild improvement, supported by stable feedstock prices and the beginning of the seasonally stronger summer period."

2Q14 Capital Expenditures and acquisitions amounted to U.S. $408 million. This figure includes U.S. $163 million corresponding to the acquisition of the majority of Campofrio shares that traded in the market purchased through a tender offer completed by Sigma in the quarter. As a result, Sigma and WH Group now own approximately 98.6% of Campofrio's equity.

ALFA's financial condition remained strong. As of June 30, 2014, Net Debt totaled U.S. $4,259 million, U.S. $1,257 million higher than 2Q13. The increase is primarily attributable to the acquisition of Campofrio, as Sigma raised roughly U.S. $600 million to fund the Campofrio acquisition, and also assumed U.S. $662 million of Campofrio's own debt as of March 31, 2014. Financial ratios at the end of 2Q14 were: Net Debt to EBITDA of 2.2 times, and Interest Coverage of 6.1 times. These figures compare with 1.6 and 6.6 times in 2Q13, respectively. The 2Q14 ratios reflect the increase in debt already explained, without the offsetting benefit to EBITDA from the Campofrio acquisition as this was closed late in the quarter.

Majority Net Income totaled U.S. $147 million in 2Q14, much higher than U.S. $8 million in 2Q13. The improved performance was primarily due to the fact that the 2Q13 results were negatively impacted by a provision for the closure of Alpek's Cape Fear plant. Exchange gains due to more favorable currency exchange rates in 2Q14 also contributed to the increase in Majority Net Income.


Selected Financial Information
(U.S. $ Millions)

Ch.%

Ch.%

2Q14

2Q13

1Q14

vs. 1Q14

vs. 2Q13

YTD '14

YTD '13

YTD
% Chg.

Consolidated Revenues

4,024

4,074

3,895

3

(1)

7,919

7,981

(1)

Alpek

1,615

1,811

1,576

2

(11)

3,191

3,637

(12)

Nemak

1,202

1,137

1,205

0

6

2,406

2,189

10

Sigma

1,037

973

952

9

7

1,989

1,857

7

Alestra

103

98

99

4

5

202

194

4

Newpek

42

32

39

8

30

81

62

30

Consolidated EBITDA

510

507

459

11

1

968

985

(2)

Alpek

126

122

105

19

3

231

282

(18)

Nemak

193

173

188

3

12

381

315

21

Sigma

135

147

117

15

(8)

252

262

(4)

Alestra

41

56

39

7

(27)

80

93

(14)

Newpek

30

24

26

17

25

56

45

25

Majority Net Income

147

8

128

15

-

276

214

29

Capex & Acquisitions

408

375

236

9

73

644

577

12

Net Debt

4,259

3,302

3,578

19

42

4,259

3,002

42

Net Debt to LTM EBITDA*

2.2

1.6

1.9

Interest Coverage*

6.1

6.6

6.4

* Times. LTM= Last 12 months.
1 EBITDA = operating income + depreciation and amortization + non-recurring items.



For further information:

Enrique Flores
Vice President, Corporate Communications
ALFA, S.A.B. de C.V.
Phone + 52 (81) 8748-1207
eflores@alfa.com.mx
distributed by